Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes

Clinical trial NCT00824668 · COMPLETED

Trial details

NCT number

NCT00824668

Sponsor

Novo Nordisk A/S

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2007-08-01

Primary completion

2007-10-01

Enrollment

24

View on ClinicalTrials.gov